AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Editas Medicine to present at investor conferences in September.
ByAinvest
Wednesday, Aug 27, 2025 9:03 am ET1min read
Editas Medicine, a gene editing company, announced management participation in three upcoming investor conferences in September. The conferences include the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Baird Global Healthcare Conference. Editas Medicine's presentations and one-on-one meetings will be available via webcast on the company's website.
Editas Medicine, Inc. (NASDAQ: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, has announced its management team's participation in three upcoming investor conferences in September. The company's presentations and one-on-one meetings will be available via webcast on the company's website.The conferences include the Wells Fargo Healthcare Conference on September 3 in Boston, the Cantor Global Healthcare Conference on September 4 in New York, and the Baird Global Healthcare Conference on September 9 in New York. These events provide investors with an opportunity to engage with Editas Medicine's management team and gain insights into the company's pipeline and future plans.
Editas Medicine's participation in these conferences follows its recent strong performance, as highlighted by a robust 34% week-to-date increase in its share price. The company's second-quarter earnings report, released on Tuesday, showed revenue of slightly under $3.6 million, up from $513,000 in the same quarter last year. Although the company missed earnings expectations, its operational update and future outlook drove investor enthusiasm [1].
The company's CEO, Gilmore O'Neill, stated that Editas is "driving toward our goal of nominating our first in vivo development candidate, which we plan to select in September." This announcement was a significant driver of the stock's performance and generated excitement among investors [1].
Investors interested in Editas Medicine's presentations and one-on-one meetings can access the live webcasts (where available) by visiting the "Investors" section of the company's website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
References:
[1] https://www.aol.com/why-editas-medicine-stock-skyrocketing-115043661.html
[2] https://www.marketscreener.com/news/editas-medicine-to-participate-in-upcoming-investor-conferences-ce7c50dedc81ff23
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet